Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Fåhraeus

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Lakartidningen|October 4, 1972
[Vacuum aspirations at a hospital outpatient clinic]R Fåhraeus
Oncogene|July 13, 2010
p53 isoforms gain functionsV Olivares-Illana, R Fåhraeus
Oncogene|October 8, 2013
MDM2's social networkR Fåhraeus, V Olivares-Illana
The EMBO Journal|April 16, 1999
The p16(INK4a) tumour suppressor protein inhibits alphavbeta3 integrin-mediated cell spreading on vitronectin by blocking PKC-dependent localization of alphavbeta3 to focal contactsR Fåhraeus, D P Lane
European Journal of Biochemistry|July 1, 1992
Biochemical characterization of Epstein-Barr virus nuclear antigen 2A and an associated ATPase activityH Randahl, R Fåhraeus, G Klein
Oncogene|December 15, 2015
Whisper mutations: cryptic messages within the genetic codeR Fåhraeus, M Marin, V Olivares-Illana
Nature|May 31, 1990
Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virusR Fåhraeus, L Rymo, J S Rhim, et al.
Oncogene|June 2, 2009
p53 and little brother p53/47: linking IRES activities with protein functionsR Grover, M M Candeias, R Fåhraeus, et al.
The Journal of Pathology|May 26, 1999
New approaches to cancer therapiesR Fåhraeus, P Fischer, E Krausz, et al.
Oncogene|March 3, 1998
Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumour suppressor moleculeR Fåhraeus, S Laín, K L Ball, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Lakartidningen|October 4, 1972
[Vacuum aspirations at a hospital outpatient clinic]R Fåhraeus
Oncogene|July 13, 2010
p53 isoforms gain functionsV Olivares-Illana, R Fåhraeus
Oncogene|October 8, 2013
MDM2's social networkR Fåhraeus, V Olivares-Illana
The EMBO Journal|April 16, 1999
The p16(INK4a) tumour suppressor protein inhibits alphavbeta3 integrin-mediated cell spreading on vitronectin by blocking PKC-dependent localization of alphavbeta3 to focal contactsR Fåhraeus, D P Lane
European Journal of Biochemistry|July 1, 1992
Biochemical characterization of Epstein-Barr virus nuclear antigen 2A and an associated ATPase activityH Randahl, R Fåhraeus, G Klein
Oncogene|December 15, 2015
Whisper mutations: cryptic messages within the genetic codeR Fåhraeus, M Marin, V Olivares-Illana
Nature|May 31, 1990
Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virusR Fåhraeus, L Rymo, J S Rhim, et al.
Oncogene|June 2, 2009
p53 and little brother p53/47: linking IRES activities with protein functionsR Grover, M M Candeias, R Fåhraeus, et al.
The Journal of Pathology|May 26, 1999
New approaches to cancer therapiesR Fåhraeus, P Fischer, E Krausz, et al.
Oncogene|March 3, 1998
Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumour suppressor moleculeR Fåhraeus, S Laín, K L Ball, et al.
Pageof 3